Mankind Pharma s IPO fails to attract enough retail investors, with the retail quota 8% unsubscribed. The company plans to raise ?4,326 crore through the IPO.
Mankind IPO will be entirely offer for sale and its proposed equity shares will list on BSE and NSE. The pharma major expects the listing of its equity shares to enhance its visibility and brand, while also providing liquidity to its existing shareholders.
Mankind Pharma IPO: The issue, which is an offer for sale, is expected to fetch the pharma company s shareholders Rs 4,326.36 crore at the upper end of the price band of Rs 1,026-1,080 a share
The company has priced the issue in the range of Rs 1,026-1,080 per share. It mobilised Rs 1,297.9 crore from a clutch of anchor investors including CPPIB, GIC, ADIA, Fidelity, Goldman Sachs and Blackrock